Health Canada has granted approval for a second generic version of semaglutide, a medication commonly found in brand-name drugs such as Ozempic, Wegovy, and Mounjaro. This new generic version is produced by Apotex, a Canadian pharmaceutical company. The approval follows the recent authorization of the first generic version of Ozempic, which was announced by Health Canada on Tuesday night. These approvals aim to increase access to semaglutide for patients requiring treatment for conditions such as obesity and type 2 diabetes.
Related Articles
Don't miss out on breaking stories and in-depth articles.